Innovative Hybridisation of Genetic Algorithms and Neural Networks in Detecting Marker Genes for Leukaemia Cancer

Methods for extracting marker genes that trigger the growth of cancerous cells from a high level of complexity microarrays are of much interest from the computing community. Through the identified genes, the pathology of cancerous cells can be revealed and early precaution can be taken to prevent further proliferation of cancerous cells. In this paper, we propose an innovative hybridised gene identification framework based on genetic algorithms and neural networks to identify marker genes for leukaemia disease. Our approach confirms that high classification accuracy does not ensure the optimal set of genes have been identified and our model delivers a more promising set of genes even with a lower classification accurac

Computational models and approaches for lung cancer diagnosis

The success of treatment of patients with cancer depends on establishing an accurate diagnosis. To this end, the aim of this study is to developed novel lung cancer diagnostic models. New algorithms are proposed to analyse the biological data and extract knowledge that assists in achieving accurate diagnosis results

Classification of microarray gene expression cancer data by using artificial intelligence methods

Günümüzde bilgisayar teknolojilerinin gelişmesi ile birçok alanda yapılan çalışmaları etkilemiştir. Moleküler biyoloji ve bilgisayar teknolojilerinde meydana gelen gelişmeler biyoinformatik adlı bilimi ortaya çıkarmıştır. Biyoinformatik alanında meydana gelen hızlı gelişmeler, bu alanda çözülmeyi bekleyen birçok probleme çözüm olma yolunda büyük katkılar sağlamıştır. DNA mikroarray gen ekspresyonlarının sınıflandırılması da bu problemlerden birisidir. DNA mikroarray çalışmaları, biyoinformatik alanında kullanılan bir teknolojidir. DNA mikroarray veri analizi, kanser gibi genlerle alakalı hastalıkların teşhisinde çok etkin bir rol oynamaktadır. Hastalık türüne bağlı gen ifadeleri belirlenerek, herhangi bir bireyin hastalıklı gene sahip olup olmadığı büyük bir başarı oranı ile tespit edilebilir. Bireyin sağlıklı olup olmadığının tespiti için, mikroarray gen ekspresyonları üzerinde yüksek performanslı sınıflandırma tekniklerinin kullanılması büyük öneme sahiptir. DNA mikroarray’lerini sınıflandırmak için birçok yöntem bulunmaktadır. Destek Vektör Makinaları, Naive Bayes, k-En yakın Komşu, Karar Ağaçları gibi birçok istatistiksel yöntemler yaygın olarak kullanlmaktadır. Fakat bu yöntemler tek başına kullanıldığında, mikroarray verilerini sınıflandırmada her zaman yüksek başarı oranları vermemektedir. Bu yüzden mikroarray verilerini sınıflandırmada yüksek başarı oranları elde etmek için yapay zekâ tabanlı yöntemlerin de kullanılması yapılan çalışmalarda görülmektedir. Bu çalışmada, bu istatistiksel yöntemlere ek olarak yapay zekâ tabanlı ANFIS gibi bir yöntemi kullanarak daha yüksek başarı oranları elde etmek amaçlanmıştır. İstatistiksel sınıflandırma yöntemleri olarak K-En Yakın Komşuluk, Naive Bayes ve Destek Vektör Makineleri kullanılmıştır. Burada Göğüs ve Merkezi Sinir Sistemi kanseri olmak üzere iki farklı kanser veri seti üzerinde çalışmalar yapılmıştır. Sonuçlardan elde edilen bilgilere göre, genel olarak yapay zekâ tabanlı ANFIS tekniğinin, istatistiksel yöntemlere göre daha başarılı olduğu tespit edilmiştir

An Overview of the Use of Neural Networks for Data Mining Tasks

In the recent years the area of data mining has experienced a considerable demand for technologies that extract knowledge from large and complex data sources. There is a substantial commercial interest as well as research investigations in the area that aim to develop new and improved approaches for extracting information, relationships, and patterns from datasets. Artificial Neural Networks (NN) are popular biologically inspired intelligent methodologies, whose classification, prediction and pattern recognition capabilities have been utilised successfully in many areas, including science, engineering, medicine, business, banking, telecommunication, and many other fields. This paper highlights from a data mining perspective the implementation of NN, using supervised and unsupervised learning, for pattern recognition, classification, prediction and cluster analysis, and focuses the discussion on their usage in bioinformatics and financial data analysis tasks

Feature selection of microarray data using genetic algorithms and artificial neural networks

Microarrays, which allow for the measurement of thousands of gene expression levels in parallel, have created a wealth of data not previously available to biologists along with new computational challenges. Microarray studies are characterized by a low sample number and a large feature space with many features irrelevant to the problem being studied. This makes feature selection a necessary pre-processing step for many analyses, particularly classification. A Genetic Algorithm -Artificial Neural Network (ANN) wrapper approach is implemented to find the highest scoring set of features for an ANN classifier. Each generation relies on the performance of a set of features trained on an ANN for fitness evaluation. A publically-available leukemia microarray data set (Golub et al., 1999), consisting of 25 AML and 47 ALL Leukemia samples, each with 7129 features, is used to evaluate this approach. Results show an increased performance over Golub\u27s initial findings

EapGAFS: Microarray Dataset for Ensemble Classification for Diseases Prediction

Microarray data stores the measured expression levels of thousands of genes simultaneously which helps the researchers to get insight into the biological and prognostic information. Cancer is a deadly disease that develops over time and involves the uncontrolled division of body cells. In cancer, many genes are responsible for cell growth and division. But different kinds of cancer are caused by a different set of genes. So to be able to better understand, diagnose and treat cancer, it is essential to know which of the genes in the cancer cells are working abnormally. The advances in data mining, machine learning, soft computing, and pattern recognition have addressed the challenges posed by the researchers to develop computationally effective models to identify the new class of disease and develop diagnostic or therapeutic targets. This paper proposed an Ensemble Aprior Gentic Algorithm Feature Selection (EapGAFS) for microarray dataset classification. The proposed algorithm comprises of the genetic algorithm implemented with aprior learning for the microarray attributes classification. The proposed EapGAFS uses the rule set mining in the genetic algorithm for the microarray dataset processing. Through framed rule set the proposed model extract the attribute features in the dataset. Finally, with the ensemble classifier model the microarray dataset were classified for the processing. The performance of the proposed EapGAFS is conventional classifiers for the collected microarray dataset of the breast cancer, Hepatities, diabeties, and bupa. The comparative analysis of the proposed EapGAFS with the conventional classifier expressed that the proposed EapGAFS exhibits improved performance in the microarray dataset classification. The performance of the proposed EapGAFS is improved ~4 – 6% than the conventional classifiers such as Adaboost and ensemble

Estimation of Relevant Variables on High-Dimensional Biological Patterns Using Iterated Weighted Kernel Functions

BACKGROUND The analysis of complex proteomic and genomic profiles involves the identification of significant markers within a set of hundreds or even thousands of variables that represent a high-dimensional problem space. The occurrence of noise, redundancy or combinatorial interactions in the profile makes the selection of relevant variables harder. METHODOLOGY/PRINCIPAL FINDINGS Here we propose a method to select variables based on estimated relevance to hidden patterns. Our method combines a weighted-kernel discriminant with an iterative stochastic probability estimation algorithm to discover the relevance distribution over the set of variables. We verified the ability of our method to select predefined relevant variables in synthetic proteome-like data and then assessed its performance on biological high-dimensional problems. Experiments were run on serum proteomic datasets of infectious diseases. The resulting variable subsets achieved classification accuracies of 99% on Human African Trypanosomiasis, 91% on Tuberculosis, and 91% on Malaria serum proteomic profiles with fewer than 20% of variables selected. Our method scaled-up to dimensionalities of much higher orders of magnitude as shown with gene expression microarray datasets in which we obtained classification accuracies close to 90% with fewer than 1% of the total number of variables. CONCLUSIONS Our method consistently found relevant variables attaining high classification accuracies across synthetic and biological datasets. Notably, it yielded very compact subsets compared to the original number of variables, which should simplify downstream biological experimentation